HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

SEXUALLY TRANSMITTED DISEASES is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the investigation and dissemination of research on sexually transmitted infections and related public health issues. This journal, with the ISSN 0148-5717 and E-ISSN 1537-4521, has been a cornerstone of the field since its inception in 1977, with coverage extended to 2024. A testament to its scholarly impact, it holds prestigious rankings in the top quartiles across various categories including Q1 in Dermatology and Q1 in Public Health, Environmental and Occupational Health, underscoring its importance in driving forward critical discussions and advancements in these vital areas of health. With an emphasis on rigorous research and the latest scientific findings, the journal not only serves researchers and professionals but also informs clinical practices, shaping public health policies. While it is not an Open Access journal, it offers a wealth of subscription-based resources highly regarded for their quality and relevance within the medical community.

Current HIV Research is a pivotal journal dedicated to the latest advancements in the field of HIV research, published by Bentham Science Publishers Ltd. With a commitment to disseminating high-quality research, this journal serves as a critical resource for researchers, healthcare professionals, and students interested in infectious diseases and virology. The journal has an ISSN of 1570-162X and an E-ISSN of 1873-4251, reflecting its commitment to contemporary digital scholarship. Given its publication history spanning from 2003 to 2024, the journal has continually provided insights and peer-reviewed articles that foster knowledge and innovation in HIV research. Although it currently holds a Q3 ranking in Infectious Diseases and a Q4 ranking in Virology, these rankings underscore its importance as an emerging platform for critical research dialogue. Despite not being an Open Access journal, 'Current HIV Research' ensures that cutting-edge studies reach relevant practitioners and contribute to ongoing discourse in the medical community. By fostering an informed approach to HIV and its implications, this journal is an invaluable asset to those committed to advancing their expertise in this crucial area of health science.

SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, published by AOSIS, stands as a vital resource in the field of Infectious Diseases, particularly focusing on HIV medicine. With an ISSN of 1608-9693 and E-ISSN 2078-6751, this Open Access journal has been dedicated to disseminating cutting-edge research since 2001, ensuring that findings are accessible to a global audience of researchers, healthcare professionals, and students. Operating out of South Africa, the journal has earned a position in the Q3 quartile for Infectious Diseases, reflecting its commitment to advancing the understanding and treatment of HIV-related issues. Its Scopus ranking, presently at #207 out of 344, further emphasizes its scholarly influence, positioning it as an essential publication within the medical community. The journal aims to foster collaboration and innovation in HIV research and practice, bridging gaps between theory and real-world application to improve health outcomes in southern Africa and beyond.

AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

Public Health Action, published by the International Union Against Tuberculosis and Lung Disease (IUATLD), is a pivotal open-access journal dedicated to advancing knowledge and practice in the fields of public health and health policy. Since its inception in 2011, the journal has provided a platform for innovative research and impactful discussions that shape the future of public health, with an emphasis on combating tuberculosis and other communicable diseases. With an ISSN of 2220-8372 and a presence in Scopus, the journal is ranked #110 in Health Policy and #249 in Public Health, Environmental and Occupational Health, showcasing its commitment to quality and relevance in its field. Housed in Paris, France, Public Health Action invites researchers, professionals, and students to explore cutting-edge research that informs policy and practice and contributes to the global fight against diseases. By offering open access to its content, the journal ensures that vital information remains accessible to a diverse audience, fostering collaboration and innovation worldwide.

AIDS AND BEHAVIOR, published by SPRINGER/PLENUM PUBLISHERS, is a leading scholarly journal dedicated to the interdisciplinary study of HIV/AIDS, focusing particularly on the behavioral aspects of the epidemic. With an impressive impact factor reflected in its Q1 rankings across key categories including Infectious Diseases, Public Health, and Social Psychology, this journal serves as a vital resource for researchers, clinicians, and public health professionals. It encompasses a wide scope of research, from the psychosocial factors influencing HIV transmission to innovative interventions that promote safe practices. Although it does not offer open access, the journal's rigorous peer-review process ensures the dissemination of high-quality, impactful research. Covering data from 1997 to 2024, AIDS AND BEHAVIOR is positioned at the forefront of advancements in the field, making it an essential addition to any academic library and a must-read for those involved in combating HIV/AIDS.

Sahara J-Journal of Social Aspects of HIV-AIDS, published by TAYLOR & FRANCIS LTD, is a distinguished open-access journal that has been contributing to the discourse surrounding HIV/AIDS since its inception in 2004. Operating from the United Kingdom, this journal aims to provide a comprehensive platform for researchers, professionals, and students to explore the social dimensions of HIV/AIDS, fostering an understanding of its impact on health, public policy, and societal norms. With an increasing impact factor and ranking within the Q3 category across various health-related fields, including Social Sciences, Infectious Diseases, and Public Health, Sahara J serves as a vital resource for interdisciplinary studies. Its commitment to open-access publishing ensures that vital research findings are freely available to a global audience, promoting widespread dissemination of knowledge and ultimately enhancing collaborative efforts to address the ongoing challenges posed by HIV/AIDS. As we navigate a rapidly evolving landscape in public health, this journal remains dedicated to advancing critical insights and fostering informed dialogues within the academic community.

HIV Research & Clinical Practice, published by Taylor & Francis Ltd, is an essential open-access journal dedicated to advancing the knowledge and understanding of HIV-related research and clinical practices. With an ISSN of 2578-7489 and E-ISSN 2578-7470, this acclaimed journal is committed to disseminating cutting-edge studies and innovative treatment strategies within the infectious diseases and pharmacology fields, achieving a commendable Q2 ranking in both categories as of 2023. The journal's scope encompasses a broad range of topics from basic science to clinical application, providing a vital platform for researchers, clinicians, and students to exchange insights and foster collaboration. As an open-access publication since 2022, it ensures that high-quality research is accessible to a global audience, encouraging a greater understanding of HIV and its implications for public health. With its base in the United Kingdom and a convergence period from 2019 to 2024, HIV Research & Clinical Practice stands at the forefront of the fight against HIV/AIDS, making significant contributions to the clinical community and beyond.